Top Industry News

The latest from CDMOs, CMOs, and suppliers featuring AGC Biologics, Samsung Biologics, Bend Bioscience and Thermo Fisher Scientific/Xcell Biosciences.   Biologics Manufacturing * AGC Biologics Begins Process Development & Clinical Mfg at…

A roundup of bio/pharmaceutical partnering news from Gilead/Kymera Therapeutics, Roche/Maia Biotechnology and Silo Pharma/Hoth Therapeutics.  * Gilead, Kymera Therapeutics in $750-M Pact for Molecular Glue Degraders for Cancer * Roche, Maia…

A roundup of news from Incyte, the CDC, Bavarian Nordic, and Pierre Fabre Laboratories. Highlights below.   Leadership Changes * Incyte Names New CEO Regulatory News * Revamped CDC Vaccine Panel Holds First MeetingGeneral *…

The US Food and Drug Administration has launched a new priority review voucher with the goal of reducing the agency’s drug review times to 1 to 2 months for certain…

Eli Lilly and Company has agreed to acquire Verve Therapeutics, a Boston-based clinical-stage bio/pharmaceutical company developing genetic medicines for cardiovascular disease, in a deal worth up to $1.3 billion ($1…

The latest from CDMOs, CMOs, and suppliers featuring Veranova, Cytiva, Enzene, Kindeva, Delpharm, ReciBioPharm, Tjoapack and Tekniplex.   Chemicals/Chemical API Manufacturing * Veranova Breaks Ground on New ADC Mfg Facility; Adding Bioconjugation…

A roundup of bio/pharmaceutical partnering news from AstraZeneca/CSPC, Regeneron/Hansoh Pharma, Teva/Fosun Pharma, GSK/Bharat Biotech, and Astellas/Mitsubishi Research Institute.  * AstraZeneca, China’s CSPC in $5.3-Bn AI Drug-Development Pact* Regeneron, Hanosh Pharma…

The latest news on mergers and acquisitions featuring. Highlights below.  * Supernus Pharma to Acquire Sage Therapeutics in $795-M Deal * Regeneron Outbid for Genetic Testing Company 23andMe  Supernus Pharma to…

Bristol Myers Squibb (BMS) and BioNTech, a Mainz-Germany-based bio/pharmaceutical company, have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody, BNT327, across numerous solid…

UCB, a Brussels, Belgium-based bio/pharmaceutical company, has announced plans to build a new US-based biomanufacturing facility and to scale up its partnerships with US-based CDMOs.   The company says that the…